<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001876996</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001157601</issuerCik>
<issuerName>Madrigal Pharmaceuticals, Inc.</issuerName>
<secFileNumber>001-33277</secFileNumber>
<issuerAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">Four Towers Bridge</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">200 Barr Harbor Drive, Suite 200</street2>
<city xmlns="http://www.sec.gov/edgar/common">West Conshohocken</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">PA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">19428</zipCode>
</issuerAddress>
<issuerContactPhone>267-824-2827</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Robert E Waltermire</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>Officer</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">1 New York Plaza, 8th Floor</street1>
<city xmlns="http://www.sec.gov/edgar/common">New York</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">10004</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>103</noOfUnitsSold>
<aggregateMarketValue>35034.42</aggregateMarketValue>
<noOfUnitsOutstanding>21810407</noOfUnitsOutstanding>
<approxSaleDate>01/24/2025</approxSaleDate>
<securitiesExchangeName>Nasdaq Stock Market</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<acquiredDate>01/23/2025</acquiredDate>
<natureOfAcquisitionTransaction>Restricted Stock Unit Grant</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>103</amountOfSecuritiesAcquired>
<paymentDate>01/23/2025</paymentDate>
<natureOfPayment>Vesting of Restricted Stock Units</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<securitiesSoldInPast3Months>
<sellerDetails>
<name>Robert E. Waltermire</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">C/O MADRIGAL PHARMACEUTICALS, INC.</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">200 BARR HARBOR DRIVE, SUITE 200</street2>
<city xmlns="http://www.sec.gov/edgar/common">WEST CONSHOHOCKEN</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">PA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">19428</zipCode>
</address>
</sellerDetails>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<saleDate>01/17/2025</saleDate>
<amountOfSecuritiesSold>442</amountOfSecuritiesSold>
<grossProceeds>120847.22</grossProceeds>
</securitiesSoldInPast3Months>
<remarks>The sale of shares of common stock reported on this Form 144 represents the sale of shares pursuant to a sell-to-cover transaction in order to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units previously granted to the Reporting Person.</remarks>
<noticeSignature>
<noticeDate>01/24/2025</noticeDate>
<signature>/s/ Robert E Waltermire</signature>
</noticeSignature>
</formData>
</edgarSubmission>
